Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence

NACompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

April 30, 2016

Conditions
Fecal Incontinence
Interventions
DEVICE

TOPAS Treatment for Fecal Incontinence

The TOPAS Treatment for Fecal Incontinence is implanted using a minimally invasive trans-obturator approach; two needle passers deliver the sling assembly. Two small posterior incisions facilitate the post-anal placement of the mesh.

Trial Locations (14)

18104

St. Luke's Hospital, Allentown

27599

University of North Carolina - Chapel Hill, Chapel Hill

30577

Raybon OB-GYN, Toccoa

33331

Cleveland Clinic Foundation - Florida, Weston

33605

University of South Florida, Tampa

44195

Cleveland Clinic Foundation - Ohio, Cleveland

45219

The Christ Hospital, Cincinnati

48109

University of Michigan, Ann Arbor

55407

Abbott Northwestern Hospital, Minneapolis

76104

University of Oklahoma, Oklahoma City

77054

Womens Hospital of Texas, Houston

94115

University of California SF - Mt Zion Medical Center, San Francisco

99204

Sacred Heart Medical Center, Spokane

07960

Atlantic Health System, Morristown

Sponsors
All Listed Sponsors
lead

ASTORA Women's Health

INDUSTRY